Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Generation of human glomerular spheroids and filtration barriers in the vascularized environment as a personalized model for glomerular diseases (DFG-MU 3797/7-1) Nov. 16, 2022 - Nov. 15, 2025 Klassifikation und Testung therapeutischer Optionen STOP-FSGS Translationaler Forschungsverbund zur Verbesserung der Diagnostik und Therapie der FSGS Nov. 1, 2022 - Oct. 31, 2025 Interaktive, erweiterte Entscheidungskompetenz für die Transplantationsnachsorge (SmartNTX) Jan. 15, 2021 - Oct. 31, 2025 Milk Transmission of Viruses: Prevention of mother to child transmission of Human T-cell leukemia Virus Type 1 (HTLV-1) (Milk-TV) Nov. 1, 2020 - Oct. 31, 2025 P147: Modelling the intestinal barrier to analyse HTLV-1 transmission Nov. 1, 2024 - Oct. 31, 2025 P157: Characterization of neoantigen-directed T-cell receptor-based cell therapies in a 3D breast cancer model Nov. 1, 2024 - Oct. 31, 2025 P151-OA: Nephronectin-Integrin: From podocyte nephronectin secretion into the ECM and back to podocyte integrity Oct. 1, 2024 - Sept. 30, 2025 Competence by repetition an reflection (CORE) (PS-IFL_Comp.by repetition an reflection) Oct. 1, 2024 - Sept. 30, 2025 Regulation Stability Analysis Intelligent Learning - ARTEMIS Experiment SpacePatch. Autarkic Tiny AI Systems for Stability Analysis of cardiovascular Regulatory Mechanisms using intraindividual Time Series Feature Aggregation and longitudinal Machine Learning. (RESIL-ARES 50WB2321) Dec. 1, 2023 - Sept. 30, 2025 D037: ACLY as a therapeutic target to promote T cell-driven antitumor immune response in IBD-associated colon cancer April 1, 2023 - Sept. 30, 2025